The Drug Delivery Partnerships team would like to extend special thanks to our Advisory Board for their contribution, expertise, enthusiasm, and dedication to this event. With special thanks to:
- Allen Downs
Sr. Executive Director, Licensing & Business Development, Purdue Pharma - Peter Kramer, PhD
Executive Director, External Science & Technology, Strategic Transactions Group, Bristol-Myers Squibb and co-Chair of the 13th Annual DDP Event - Bob Nissen
Former VP, Business Development and Licensing, Novartis Consumer Health;
New Technology Consultant, Bayer Healthcare - Vickie O’Neil
Vice President, Research & Technology, Upsher-Smith Laboratories - Willie Quinn
Director, Licensing & Acquisitions, Jazz Pharmaceuticals - Jonathan Rigby
Vice President, Business Development, Zogenix - Vik Seoni
Vice President, Business Development, Endo Pharmaceuticals
and co-Chair of the 13th Annual DDP Event - Lee Shorter
Open Innovation R&D Team, GlaxoSmithKline - Philip Smith, PhD
General Partner, SR One - Brett Zbar, MD
Partner, Aisling Capital